Evidence map›Paper›PMID 40981510›Full record

ArticleBioinformatics (Oxford, England)2025

HyperPhS: a pharmacophore-guided multimodal representation framework for metabolic stability prediction through contrastive hypergraph learning.

Xiaoyi Liu, Na Zhang, Chenglong Kang, Chengwei Ai, Hongpeng Yang, Jijun Tang, Fei Guo

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaoyi LiuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.
Na ZhangComputer Science and Engineering, Central South University, Changsha 410083, China.
Chenglong KangComputer Science and Engineering, Central South University, Changsha 410083, China.
Chengwei AiComputer Science and Engineering, Central South University, Changsha 410083, China.
Hongpeng YangComputer Science and Engineering, University of South Carolina, Columbia, SC 29208, United States.
Jijun TangComputer Science and Engineering, Shenzhen University of Advanced Technology, Nanshan 518055, China.
Fei GuoComputer Science and Engineering, Central South University, Changsha 410083, China.ORCID 0000-0001-8346-0798

Funding

Fundamental Research Funds for the Central Universities 2025-JYB-XJSJJ008High-Performance Computing Center of Central South University and the High-Performance Computing Clusters PL-17161National Natural Science Foundation of China 62322215National Natural Science Foundation of China 62502050National Natural Science Foundation of China 62532017National Natural Science Foundation of China U24A20257Shenzhen Science and Technology Program JCYJ20241202130212016Shenzhen Science and Technology Program KQTD20200820113106007
6 · The paper itself

Abstract

motivationMetabolic stability is crucial in the early stage of drug discovery and development. Drug candidate screening and optimization can be streamlined through the accurate prediction of stability. Functional groups within drug molecules are known as pharmacophores, which bind directly to receptors or biological macromolecules to produce biological effects, thereby affecting metabolic stability. Therefore, determining metabolic stability via the pharmacophore groups remains a significant challenge.

resultsTo address these issues, we propose a Pharmacophore-guided Hypergraph representation framework for predicting metabolic Stability (HyperPhS). In this study, we introduce a hypergraph-based method to extract features from metabolic pharmacophores with multi-view representation and contrastive learning. In particular, we introduce a pharmacophore-based contrastive learning encoder that captures the consistency between functional and nonfunctional structures. Our method applies ChatGPT simultaneously to metabolites and heterogeneous encoders and integrates multimodal representations by using attention-driven fusion modules coupled with fully connected neural networks. On the HLM dataset, HyperPhS achieves outstanding performance with 87.6% in AUC and 62.6% in MCC, alongside an external test AUC of 88.3%. In addition, pharmacophore groups studied by HyperPhS are validated for their interpretability through case studies. Overall, HyperPhS is an effective and interpretable tool for determining metabolic stability, identifying critical functional groups, and optimizing compounds. AVAILABILITY AND IMPLEMENTATION: The code and data are available at https://github.com/xiaoyiliu-usc/HyperPhS.

Indexed as

Computational BiologyDrug DiscoveryMachine LearningAlgorithmsHumansNeural Networks, ComputerPharmacophore

Identifiers

PMID40981510
PMCPMC12574321

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.